Global Psychedelic Drugs Market 2021 by Company, Regions, Type and Application, Forecast to 2026
Page: 113
Published Date: 21 Oct 2021
Category: Medical Care
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The Psychedelic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Psychedelic Drugs size is estimated to be USD million in 2026 from USD million in 2020, with a change % between 2020 and 2021. The global Psychedelic Drugs market size is expected to grow at a CAGR of % for the next five years.
Market segmentation
Psychedelic Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Psilocybin
LSD
MDMA
DMT
Ketamine
Others
Market segment by Application, can be divided into
Depressive Disorders
Post-Traumatic Stress Disorders
Substance Abuse Disorders
Obsessive Compulsive Disorders
Others
Market segment by players, this report covers
COMPASS Pathways PLC
Pfizer
Eli Lilly
GlaxoSmithKline
Cybin Inc
Field Trip Health
ATAI Life Sciences
NUMINUS WELLNESS
MindMed
HAVN Life Sciences
Seelos Therapeutics
Jannsen
Acadia Pharmaceuticals
Intellipharmaceutics
Revive Therapeutics
Mydecine Innovations Group
Red Light Holland
Braxia Scientific
Mind Cure Health
Entheon Biomedical
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Psychedelic Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Psychedelic Drugs, with revenue, gross margin and global market share of Psychedelic Drugs from 2019 to 2021.
Chapter 3, the Psychedelic Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Psychedelic Drugs market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Psychedelic Drugs research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Psychedelic Drugs
1.2 Classification of Psychedelic Drugs by Type
1.2.1 Overview: Global Psychedelic Drugs Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Psychedelic Drugs Revenue Market Share by Type in 2020
1.2.3 Psilocybin
1.2.4 LSD
1.2.5 MDMA
1.2.6 DMT
1.2.7 Ketamine
1.2.8 Others
1.3 Global Psychedelic Drugs Market by Application
1.3.1 Overview: Global Psychedelic Drugs Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Depressive Disorders
1.3.3 Post-Traumatic Stress Disorders
1.3.4 Substance Abuse Disorders
1.3.5 Obsessive Compulsive Disorders
1.3.6 Others
1.4 Global Psychedelic Drugs Market Size & Forecast
1.5 Global Psychedelic Drugs Market Size and Forecast by Region
1.5.1 Global Psychedelic Drugs Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Psychedelic Drugs Market Size by Region, (2016-2021)
1.5.3 North America Psychedelic Drugs Market Size and Prospect (2016-2026)
1.5.4 Europe Psychedelic Drugs Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Psychedelic Drugs Market Size and Prospect (2016-2026)
1.5.6 South America Psychedelic Drugs Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Psychedelic Drugs Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Psychedelic Drugs Market Drivers
1.6.2 Psychedelic Drugs Market Restraints
1.6.3 Psychedelic Drugs Trends Analysis
2.1 COMPASS Pathways PLC
2.1.1 COMPASS Pathways PLC Details
2.1.2 COMPASS Pathways PLC Major Business
2.1.3 COMPASS Pathways PLC Psychedelic Drugs Product and Solutions
2.1.4 COMPASS Pathways PLC Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 COMPASS Pathways PLC Recent Developments and Future Plans
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Psychedelic Drugs Product and Solutions
2.2.4 Pfizer Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Pfizer Recent Developments and Future Plans
2.3 Eli Lilly
2.3.1 Eli Lilly Details
2.3.2 Eli Lilly Major Business
2.3.3 Eli Lilly Psychedelic Drugs Product and Solutions
2.3.4 Eli Lilly Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Eli Lilly Recent Developments and Future Plans
2.4 GlaxoSmithKline
2.4.1 GlaxoSmithKline Details
2.4.2 GlaxoSmithKline Major Business
2.4.3 GlaxoSmithKline Psychedelic Drugs Product and Solutions
2.4.4 GlaxoSmithKline Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 GlaxoSmithKline Recent Developments and Future Plans
2.5 Cybin Inc
2.5.1 Cybin Inc Details
2.5.2 Cybin Inc Major Business
2.5.3 Cybin Inc Psychedelic Drugs Product and Solutions
2.5.4 Cybin Inc Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Cybin Inc Recent Developments and Future Plans
2.6 Field Trip Health
2.6.1 Field Trip Health Details
2.6.2 Field Trip Health Major Business
2.6.3 Field Trip Health Psychedelic Drugs Product and Solutions
2.6.4 Field Trip Health Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Field Trip Health Recent Developments and Future Plans
2.7 ATAI Life Sciences
2.7.1 ATAI Life Sciences Details
2.7.2 ATAI Life Sciences Major Business
2.7.3 ATAI Life Sciences Psychedelic Drugs Product and Solutions
2.7.4 ATAI Life Sciences Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 ATAI Life Sciences Recent Developments and Future Plans
2.8 NUMINUS WELLNESS
2.8.1 NUMINUS WELLNESS Details
2.8.2 NUMINUS WELLNESS Major Business
2.8.3 NUMINUS WELLNESS Psychedelic Drugs Product and Solutions
2.8.4 NUMINUS WELLNESS Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 NUMINUS WELLNESS Recent Developments and Future Plans
2.9 MindMed
2.9.1 MindMed Details
2.9.2 MindMed Major Business
2.9.3 MindMed Psychedelic Drugs Product and Solutions
2.9.4 MindMed Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 MindMed Recent Developments and Future Plans
2.10 HAVN Life Sciences
2.10.1 HAVN Life Sciences Details
2.10.2 HAVN Life Sciences Major Business
2.10.3 HAVN Life Sciences Psychedelic Drugs Product and Solutions
2.10.4 HAVN Life Sciences Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 HAVN Life Sciences Recent Developments and Future Plans
2.11 Seelos Therapeutics
2.11.1 Seelos Therapeutics Details
2.11.2 Seelos Therapeutics Major Business
2.11.3 Seelos Therapeutics Psychedelic Drugs Product and Solutions
2.11.4 Seelos Therapeutics Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Seelos Therapeutics Recent Developments and Future Plans
2.12 Jannsen
2.12.1 Jannsen Details
2.12.2 Jannsen Major Business
2.12.3 Jannsen Psychedelic Drugs Product and Solutions
2.12.4 Jannsen Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Jannsen Recent Developments and Future Plans
2.13 Acadia Pharmaceuticals
2.13.1 Acadia Pharmaceuticals Details
2.13.2 Acadia Pharmaceuticals Major Business
2.13.3 Acadia Pharmaceuticals Psychedelic Drugs Product and Solutions
2.13.4 Acadia Pharmaceuticals Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Acadia Pharmaceuticals Recent Developments and Future Plans
2.14 Intellipharmaceutics
2.14.1 Intellipharmaceutics Details
2.14.2 Intellipharmaceutics Major Business
2.14.3 Intellipharmaceutics Psychedelic Drugs Product and Solutions
2.14.4 Intellipharmaceutics Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Intellipharmaceutics Recent Developments and Future Plans
2.15 Revive Therapeutics
2.15.1 Revive Therapeutics Details
2.15.2 Revive Therapeutics Major Business
2.15.3 Revive Therapeutics Psychedelic Drugs Product and Solutions
2.15.4 Revive Therapeutics Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Revive Therapeutics Recent Developments and Future Plans
2.16 Mydecine Innovations Group
2.16.1 Mydecine Innovations Group Details
2.16.2 Mydecine Innovations Group Major Business
2.16.3 Mydecine Innovations Group Psychedelic Drugs Product and Solutions
2.16.4 Mydecine Innovations Group Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Mydecine Innovations Group Recent Developments and Future Plans
2.17 Red Light Holland
2.17.1 Red Light Holland Details
2.17.2 Red Light Holland Major Business
2.17.3 Red Light Holland Psychedelic Drugs Product and Solutions
2.17.4 Red Light Holland Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 Red Light Holland Recent Developments and Future Plans
2.18 Braxia Scientific
2.18.1 Braxia Scientific Details
2.18.2 Braxia Scientific Major Business
2.18.3 Braxia Scientific Psychedelic Drugs Product and Solutions
2.18.4 Braxia Scientific Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.18.5 Braxia Scientific Recent Developments and Future Plans
2.19 Mind Cure Health
2.19.1 Mind Cure Health Details
2.19.2 Mind Cure Health Major Business
2.19.3 Mind Cure Health Psychedelic Drugs Product and Solutions
2.19.4 Mind Cure Health Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.19.5 Mind Cure Health Recent Developments and Future Plans
2.20 Entheon Biomedical
2.20.1 Entheon Biomedical Details
2.20.2 Entheon Biomedical Major Business
2.20.3 Entheon Biomedical Psychedelic Drugs Product and Solutions
2.20.4 Entheon Biomedical Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.20.5 Entheon Biomedical Recent Developments and Future Plans
3.1 Global Psychedelic Drugs Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Psychedelic Drugs Players Market Share
3.2.2 Top 10 Psychedelic Drugs Players Market Share
3.2.3 Market Competition Trend
3.3 Psychedelic Drugs Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4.1 Global Psychedelic Drugs Revenue and Market Share by Type (2016-2021)
4.2 Global Psychedelic Drugs Market Forecast by Type (2021-2026)
5.1 Global Psychedelic Drugs Revenue Market Share by Application (2016-2021)
5.2 Psychedelic Drugs Market Forecast by Application (2021-2026)
6.1 North America Psychedelic Drugs Revenue by Type (2016-2026)
6.2 North America Psychedelic Drugs Revenue by Application (2016-2026)
6.3 North America Psychedelic Drugs Market Size by Country
6.3.1 North America Psychedelic Drugs Revenue by Country (2016-2026)
6.3.2 United States Psychedelic Drugs Market Size and Forecast (2016-2026)
6.3.3 Canada Psychedelic Drugs Market Size and Forecast (2016-2026)
6.3.4 Mexico Psychedelic Drugs Market Size and Forecast (2016-2026)
7.1 Europe Psychedelic Drugs Revenue by Type (2016-2026)
7.2 Europe Psychedelic Drugs Revenue by Application (2016-2026)
7.3 Europe Psychedelic Drugs Market Size by Country
7.3.1 Europe Psychedelic Drugs Revenue by Country (2016-2026)
7.3.2 Germany Psychedelic Drugs Market Size and Forecast (2016-2026)
7.3.3 France Psychedelic Drugs Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Psychedelic Drugs Market Size and Forecast (2016-2026)
7.3.5 Russia Psychedelic Drugs Market Size and Forecast (2016-2026)
7.3.6 Italy Psychedelic Drugs Market Size and Forecast (2016-2026)
8.1 Asia-Pacific Psychedelic Drugs Revenue by Type (2016-2026)
8.2 Asia-Pacific Psychedelic Drugs Revenue by Application (2016-2026)
8.3 Asia-Pacific Psychedelic Drugs Market Size by Region
8.3.1 Asia-Pacific Psychedelic Drugs Revenue by Region (2016-2026)
8.3.2 China Psychedelic Drugs Market Size and Forecast (2016-2026)
8.3.3 Japan Psychedelic Drugs Market Size and Forecast (2016-2026)
8.3.4 South Korea Psychedelic Drugs Market Size and Forecast (2016-2026)
8.3.5 India Psychedelic Drugs Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Psychedelic Drugs Market Size and Forecast (2016-2026)
8.3.7 Australia Psychedelic Drugs Market Size and Forecast (2016-2026)
9.1 South America Psychedelic Drugs Revenue by Type (2016-2026)
9.2 South America Psychedelic Drugs Revenue by Application (2016-2026)
9.3 South America Psychedelic Drugs Market Size by Country
9.3.1 South America Psychedelic Drugs Revenue by Country (2016-2026)
9.3.2 Brazil Psychedelic Drugs Market Size and Forecast (2016-2026)
9.3.3 Argentina Psychedelic Drugs Market Size and Forecast (2016-2026)
10.1 Middle East & Africa Psychedelic Drugs Revenue by Type (2016-2026)
10.2 Middle East & Africa Psychedelic Drugs Revenue by Application (2016-2026)
10.3 Middle East & Africa Psychedelic Drugs Market Size by Country
10.3.1 Middle East & Africa Psychedelic Drugs Revenue by Country (2016-2026)
10.3.2 Turkey Psychedelic Drugs Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Psychedelic Drugs Market Size and Forecast (2016-2026)
10.3.4 UAE Psychedelic Drugs Market Size and Forecast (2016-2026)
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Psychedelic Drugs Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Psychedelic Drugs Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Psychedelic Drugs Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Psychedelic Drugs Revenue (USD Million) by Region (2016-2021)
Table 5. Global Psychedelic Drugs Revenue Market Share by Region (2021-2026)
Table 6. COMPASS Pathways PLC Corporate Information, Head Office, and Major Competitors
Table 7. COMPASS Pathways PLC Major Business
Table 8. COMPASS Pathways PLC Psychedelic Drugs Product and Solutions
Table 9. COMPASS Pathways PLC Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Pfizer Corporate Information, Head Office, and Major Competitors
Table 11. Pfizer Major Business
Table 12. Pfizer Psychedelic Drugs Product and Solutions
Table 13. Pfizer Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 15. Eli Lilly Major Business
Table 16. Eli Lilly Psychedelic Drugs Product and Solutions
Table 17. Eli Lilly Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 19. GlaxoSmithKline Major Business
Table 20. GlaxoSmithKline Psychedelic Drugs Product and Solutions
Table 21. GlaxoSmithKline Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Cybin Inc Corporate Information, Head Office, and Major Competitors
Table 23. Cybin Inc Major Business
Table 24. Cybin Inc Psychedelic Drugs Product and Solutions
Table 25. Cybin Inc Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Field Trip Health Corporate Information, Head Office, and Major Competitors
Table 27. Field Trip Health Major Business
Table 28. Field Trip Health Psychedelic Drugs Product and Solutions
Table 29. Field Trip Health Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. ATAI Life Sciences Corporate Information, Head Office, and Major Competitors
Table 31. ATAI Life Sciences Major Business
Table 32. ATAI Life Sciences Psychedelic Drugs Product and Solutions
Table 33. ATAI Life Sciences Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. NUMINUS WELLNESS Corporate Information, Head Office, and Major Competitors
Table 35. NUMINUS WELLNESS Major Business
Table 36. NUMINUS WELLNESS Psychedelic Drugs Product and Solutions
Table 37. NUMINUS WELLNESS Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. MindMed Corporate Information, Head Office, and Major Competitors
Table 39. MindMed Major Business
Table 40. MindMed Psychedelic Drugs Product and Solutions
Table 41. MindMed Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. HAVN Life Sciences Corporate Information, Head Office, and Major Competitors
Table 43. HAVN Life Sciences Major Business
Table 44. HAVN Life Sciences Psychedelic Drugs Product and Solutions
Table 45. HAVN Life Sciences Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Seelos Therapeutics Corporate Information, Head Office, and Major Competitors
Table 47. Seelos Therapeutics Major Business
Table 48. Seelos Therapeutics Psychedelic Drugs Product and Solutions
Table 49. Seelos Therapeutics Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Jannsen Corporate Information, Head Office, and Major Competitors
Table 51. Jannsen Major Business
Table 52. Jannsen Psychedelic Drugs Product and Solutions
Table 53. Jannsen Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Acadia Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 55. Acadia Pharmaceuticals Major Business
Table 56. Acadia Pharmaceuticals Psychedelic Drugs Product and Solutions
Table 57. Acadia Pharmaceuticals Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Intellipharmaceutics Corporate Information, Head Office, and Major Competitors
Table 59. Intellipharmaceutics Major Business
Table 60. Intellipharmaceutics Psychedelic Drugs Product and Solutions
Table 61. Intellipharmaceutics Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Revive Therapeutics Corporate Information, Head Office, and Major Competitors
Table 63. Revive Therapeutics Major Business
Table 64. Revive Therapeutics Psychedelic Drugs Product and Solutions
Table 65. Revive Therapeutics Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Mydecine Innovations Group Corporate Information, Head Office, and Major Competitors
Table 67. Mydecine Innovations Group Major Business
Table 68. Mydecine Innovations Group Psychedelic Drugs Product and Solutions
Table 69. Mydecine Innovations Group Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Red Light Holland Corporate Information, Head Office, and Major Competitors
Table 71. Red Light Holland Major Business
Table 72. Red Light Holland Psychedelic Drugs Product and Solutions
Table 73. Red Light Holland Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. Braxia Scientific Corporate Information, Head Office, and Major Competitors
Table 75. Braxia Scientific Major Business
Table 76. Braxia Scientific Psychedelic Drugs Product and Solutions
Table 77. Braxia Scientific Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 78. Mind Cure Health Corporate Information, Head Office, and Major Competitors
Table 79. Mind Cure Health Major Business
Table 80. Mind Cure Health Psychedelic Drugs Product and Solutions
Table 81. Mind Cure Health Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 82. Entheon Biomedical Corporate Information, Head Office, and Major Competitors
Table 83. Entheon Biomedical Major Business
Table 84. Entheon Biomedical Psychedelic Drugs Product and Solutions
Table 85. Entheon Biomedical Psychedelic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 86. Global Psychedelic Drugs Revenue (USD Million) by Players (2019-2021)
Table 87. Global Psychedelic Drugs Revenue Share by Players (2019-2021)
Table 88. Breakdown of Psychedelic Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 89. Psychedelic Drugs Players Head Office, Products and Services Provided
Table 90. Psychedelic Drugs Mergers & Acquisitions in the Past Five Years
Table 91. Psychedelic Drugs New Entrants and Expansion Plans
Table 92. Global Psychedelic Drugs Revenue (USD Million) by Type (2016-2021)
Table 93. Global Psychedelic Drugs Revenue Share by Type (2016-2021)
Table 94. Global Psychedelic Drugs Revenue Forecast by Type (2021-2026)
Table 95. Global Psychedelic Drugs Revenue by Application (2016-2021)
Table 96. Global Psychedelic Drugs Revenue Forecast by Application (2021-2026)
Table 97. North America Psychedelic Drugs Revenue by Type (2016-2021) & (USD Million)
Table 98. North America Psychedelic Drugs Revenue by Type (2021-2026) & (USD Million)
Table 99. North America Psychedelic Drugs Revenue by Application (2016-2021) & (USD Million)
Table 100. North America Psychedelic Drugs Revenue by Application (2021-2026) & (USD Million)
Table 101. North America Psychedelic Drugs Revenue by Country (2016-2021) & (USD Million)
Table 102. North America Psychedelic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 103. Europe Psychedelic Drugs Revenue by Type (2016-2021) & (USD Million)
Table 104. Europe Psychedelic Drugs Revenue by Type (2021-2026) & (USD Million)
Table 105. Europe Psychedelic Drugs Revenue by Application (2016-2021) & (USD Million)
Table 106. Europe Psychedelic Drugs Revenue by Application (2021-2026) & (USD Million)
Table 107. Europe Psychedelic Drugs Revenue by Country (2016-2021) & (USD Million)
Table 108. Europe Psychedelic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 109. Asia-Pacific Psychedelic Drugs Revenue by Type (2016-2021) & (USD Million)
Table 110. Asia-Pacific Psychedelic Drugs Revenue by Type (2021-2026) & (USD Million)
Table 111. Asia-Pacific Psychedelic Drugs Revenue by Application (2016-2021) & (USD Million)
Table 112. Asia-Pacific Psychedelic Drugs Revenue by Application (2021-2026) & (USD Million)
Table 113. Asia-Pacific Psychedelic Drugs Revenue by Region (2016-2021) & (USD Million)
Table 114. Asia-Pacific Psychedelic Drugs Revenue by Region (2021-2026) & (USD Million)
Table 115. South America Psychedelic Drugs Revenue by Type (2016-2021) & (USD Million)
Table 116. South America Psychedelic Drugs Revenue by Type (2021-2026) & (USD Million)
Table 117. South America Psychedelic Drugs Revenue by Application (2016-2021) & (USD Million)
Table 118. South America Psychedelic Drugs Revenue by Application (2021-2026) & (USD Million)
Table 119. South America Psychedelic Drugs Revenue by Country (2016-2021) & (USD Million)
Table 120. South America Psychedelic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 121. Middle East & Africa Psychedelic Drugs Revenue by Type (2016-2021) & (USD Million)
Table 122. Middle East & Africa Psychedelic Drugs Revenue by Type (2021-2026) & (USD Million)
Table 123. Middle East & Africa Psychedelic Drugs Revenue by Application (2016-2021) & (USD Million)
Table 124. Middle East & Africa Psychedelic Drugs Revenue by Application (2021-2026) & (USD Million)
Table 125. Middle East & Africa Psychedelic Drugs Revenue by Country (2016-2021) & (USD Million)
Table 126. Middle East & Africa Psychedelic Drugs Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Psychedelic Drugs Picture
Figure 2. Global Psychedelic Drugs Revenue Market Share by Type in 2020
Figure 3. Psilocybin
Figure 4. LSD
Figure 5. MDMA
Figure 6. DMT
Figure 7. Ketamine
Figure 8. Others
Figure 9. Psychedelic Drugs Revenue Market Share by Application in 2020
Figure 10. Depressive Disorders Picture
Figure 11. Post-Traumatic Stress Disorders Picture
Figure 12. Substance Abuse Disorders Picture
Figure 13. Obsessive Compulsive Disorders Picture
Figure 14. Others Picture
Figure 15. Global Psychedelic Drugs Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 16. Global Psychedelic Drugs Revenue and Forecast (2016-2026) & (USD Million)
Figure 17. Global Psychedelic Drugs Revenue Market Share by Region (2016-2026)
Figure 18. Global Psychedelic Drugs Revenue Market Share by Region in 2020
Figure 19. North America Psychedelic Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Europe Psychedelic Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Asia-Pacific Psychedelic Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. South America Psychedelic Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 23. Middle East and Africa Psychedelic Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 24. Psychedelic Drugs Market Drivers
Figure 25. Psychedelic Drugs Market Restraints
Figure 26. Psychedelic Drugs Market Trends
Figure 27. COMPASS Pathways PLC Recent Developments and Future Plans
Figure 28. Pfizer Recent Developments and Future Plans
Figure 29. Eli Lilly Recent Developments and Future Plans
Figure 30. GlaxoSmithKline Recent Developments and Future Plans
Figure 31. Cybin Inc Recent Developments and Future Plans
Figure 32. Field Trip Health Recent Developments and Future Plans
Figure 33. ATAI Life Sciences Recent Developments and Future Plans
Figure 34. NUMINUS WELLNESS Recent Developments and Future Plans
Figure 35. MindMed Recent Developments and Future Plans
Figure 36. HAVN Life Sciences Recent Developments and Future Plans
Figure 37. Seelos Therapeutics Recent Developments and Future Plans
Figure 38. Jannsen Recent Developments and Future Plans
Figure 39. Acadia Pharmaceuticals Recent Developments and Future Plans
Figure 40. Intellipharmaceutics Recent Developments and Future Plans
Figure 41. Revive Therapeutics Recent Developments and Future Plans
Figure 42. Mydecine Innovations Group Recent Developments and Future Plans
Figure 43. Red Light Holland Recent Developments and Future Plans
Figure 44. Braxia Scientific Recent Developments and Future Plans
Figure 45. Mind Cure Health Recent Developments and Future Plans
Figure 46. Entheon Biomedical Recent Developments and Future Plans
Figure 47. Global Psychedelic Drugs Revenue Share by Players in 2020
Figure 48. Psychedelic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 49. Global Top 3 Players Psychedelic Drugs Revenue Market Share in 2020
Figure 50. Global Top 10 Players Psychedelic Drugs Revenue Market Share in 2020
Figure 51. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 52. Global Psychedelic Drugs Revenue Share by Type in 2020
Figure 53. Global Psychedelic Drugs Market Share Forecast by Type (2021-2026)
Figure 54. Global Psychedelic Drugs Revenue Share by Application in 2020
Figure 55. Global Psychedelic Drugs Market Share Forecast by Application (2021-2026)
Figure 56. North America Psychedelic Drugs Sales Market Share by Type (2016-2026)
Figure 57. North America Psychedelic Drugs Sales Market Share by Application (2016-2026)
Figure 58. North America Psychedelic Drugs Revenue Market Share by Country (2016-2026)
Figure 59. United States Psychedelic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Canada Psychedelic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Mexico Psychedelic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Europe Psychedelic Drugs Sales Market Share by Type (2016-2026)
Figure 63. Europe Psychedelic Drugs Sales Market Share by Application (2016-2026)
Figure 64. Europe Psychedelic Drugs Revenue Market Share by Country (2016-2026)
Figure 65. Germany Psychedelic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. France Psychedelic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. United Kingdom Psychedelic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Russia Psychedelic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Italy Psychedelic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Asia-Pacific Psychedelic Drugs Sales Market Share by Type (2016-2026)
Figure 71. Asia-Pacific Psychedelic Drugs Sales Market Share by Application (2016-2026)
Figure 72. Asia-Pacific Psychedelic Drugs Revenue Market Share by Region (2016-2026)
Figure 73. China Psychedelic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Japan Psychedelic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Korea Psychedelic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. India Psychedelic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Southeast Asia Psychedelic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Australia Psychedelic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. South America Psychedelic Drugs Sales Market Share by Type (2016-2026)
Figure 80. South America Psychedelic Drugs Sales Market Share by Application (2016-2026)
Figure 81. South America Psychedelic Drugs Revenue Market Share by Country (2016-2026)
Figure 82. Brazil Psychedelic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. Argentina Psychedelic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. Middle East and Africa Psychedelic Drugs Sales Market Share by Type (2016-2026)
Figure 85. Middle East and Africa Psychedelic Drugs Sales Market Share by Application (2016-2026)
Figure 86. Middle East and Africa Psychedelic Drugs Revenue Market Share by Country (2016-2026)
Figure 87. Turkey Psychedelic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 88. Saudi Arabia Psychedelic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 89. UAE Psychedelic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 90. Methodology
Figure 91. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
COMPASS Pathways PLC Pfizer Eli Lilly GlaxoSmithKline Cybin Inc Field Trip Health ATAI Life Sciences NUMINUS WELLNESS MindMed HAVN Life Sciences Seelos Therapeutics Jannsen Acadia Pharmaceuticals Intellipharmaceutics Revive Therapeutics Mydecine Innovations Group Red Light Holland Braxia Scientific Mind Cure Health Entheon Biomedical
Related Reports
18 Jan 2022
Medical Care
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
